# Regulatory Compliance in the Urology Domain

## Overview

Regulatory compliance shapes the design of the urology domain model by imposing constraints on data handling, device management, clinical documentation, and research protocols. The urology domain must comply with healthcare privacy regulations (HIPAA), medical device regulations (FDA), clinical documentation requirements (CMS), quality reporting programs (MIPS), and clinical trial governance (FDA/ICH-GCP). These regulatory requirements influence aggregate design, event recording, data retention, and access control throughout the domain model.

## HIPAA Compliance

The Health Insurance Portability and Accountability Act (HIPAA) governs the protection of patient health information (PHI) in the urology domain.

### Privacy Rule

All bounded contexts handle PHI and must enforce the minimum necessary standard: each context accesses only the PHI required for its specific function. The Clinical Assessment Context accesses diagnostic data. The Surgical Management Context accesses operative data. The Oncologic Context accesses cancer-related data. Anti-corruption layers between contexts must filter PHI to ensure that only relevant information crosses context boundaries.

### Security Rule

Technical safeguards required by HIPAA directly affect the domain model's infrastructure layer. Access controls enforce role-based permissions: only authorized urologists can view oncologic staging data, only the treating surgeon can modify operative records, and only credentialed laboratory personnel can submit pathology results. Audit logging captures every access to PHI, creating an immutable audit trail that the domain model's event store naturally supports.

### Breach Notification

The domain model must support breach detection and notification requirements. Event-driven architecture provides a natural mechanism for breach detection: anomalous access patterns (unusual volume of record access, access outside normal hours, access to records outside the provider's patient panel) can be detected by analyzing the event stream. The notification timeline (60 days for affected individuals) must be tracked as a compliance obligation within the system.

## FDA Medical Device Regulations

Several components of the urology domain interact with FDA-regulated medical devices, affecting domain model design.

### Robotic Surgical Systems

The da Vinci and other robotic surgical platforms are FDA-regulated Class II medical devices. The Surgical Management Context must maintain records of device model, serial number, software version, maintenance history, and adverse event reports. The domain model tracks device utilization per case to support FDA post-market surveillance requirements and mandatory adverse event reporting (MedWatch).

### Sacral Neuromodulation Devices

Implantable neuromodulation devices (InterStim, Axonics) are FDA-regulated devices requiring tracking of implant date, device serial number, programming parameters, and patient outcomes. The Incontinence Management Context maintains a DeviceImplant entity that satisfies FDA unique device identification (UDI) tracking requirements and supports adverse event reporting.

### Penile Prostheses

Inflatable and malleable penile prostheses are FDA-regulated devices tracked within the Male Reproductive Health Context. The domain model records device type, serial number, implant date, revision history, and functional outcomes to satisfy FDA post-market surveillance and institutional quality requirements.

## Clinical Documentation Requirements

The Centers for Medicare and Medicaid Services (CMS) imposes documentation requirements that affect how clinical data is structured in the domain model.

### Operative Reports

Surgical Management Context operative reports must include specific elements: pre-operative diagnosis, post-operative diagnosis, procedure name, surgeon and assistant names, type of anesthesia, findings, technical procedure description, estimated blood loss, specimens removed, complications, and disposition. The SurgicalCase aggregate enforces completeness of these required elements before the case record can be finalized.

### Evaluation and Management Documentation

Clinical Assessment Context documentation must support the level of service billed. The diagnostic workup documentation must demonstrate the complexity of medical decision-making through the number and complexity of problems addressed, the amount of data reviewed, and the risk of complications or morbidity.

## Quality Reporting

### MIPS (Merit-Based Incentive Payment System)

The urology domain model supports quality measure reporting for MIPS. Relevant quality measures include appropriate PSA screening documentation, perioperative antibiotic timing, surgical site infection rates, and patient-reported outcome measures. Each bounded context produces the data elements needed for quality measure calculation as a natural byproduct of its clinical documentation.

### AUA Quality Registry (AQUA)

The AUA Quality Registry collects urological quality data for benchmarking and improvement. The domain model's event store and aggregate data support automated extraction of quality metrics, including surgical outcomes, complication rates, cancer detection rates, and patient-reported outcomes.

## Clinical Trial Compliance

### ICH-GCP (International Council for Harmonisation - Good Clinical Practice)

When the urology domain supports clinical research, it must comply with ICH-GCP guidelines for clinical trial conduct. The domain model must support protocol-defined data collection, adverse event reporting, subject randomization, and source document verification. Separate research-specific entities track informed consent, eligibility verification, protocol deviations, and data query resolution.

### FDA 21 CFR Part 11

Electronic records used in FDA-regulated clinical trials must comply with 21 CFR Part 11 requirements for electronic signatures and records. The domain model's event store provides an immutable, timestamped record of all data changes that satisfies the audit trail requirement. Electronic signatures with signer authentication satisfy the electronic signature requirements.

## Data Retention

Regulatory requirements dictate data retention policies across the urology domain. Medical records must be retained according to state-specific requirements (typically 7-10 years after last encounter, longer for minors). Clinical trial data must be retained for 2 years after drug approval or investigation termination. Device tracking records must be maintained for the lifetime of the device plus a specified period. The domain model's event store supports long-term data retention with immutable historical records.

## Compliance as Domain Logic

Regulatory compliance is not an afterthought but an integral part of the domain model. Compliance rules are encoded as business rules within aggregates and domain services. Required documentation elements are enforced by aggregate invariants. Audit trail generation is a natural consequence of event-driven architecture. Access control enforcement is a cross-cutting concern applied consistently across all bounded contexts.

## References

- Evans, Eric. Domain-Driven Design: Tackling Complexity in the Heart of Software. Addison-Wesley, 2003.
- Vernon, Vaughn. Implementing Domain-Driven Design. Addison-Wesley, 2013.
- Khononov, Vlad. Learning Domain-Driven Design. O'Reilly Media, 2021.
- U.S. Department of Health and Human Services. HIPAA Privacy Rule. 45 CFR Parts 160 and 164.
- U.S. Food and Drug Administration. Medical Device Regulations. 21 CFR Parts 800-1299.
- Centers for Medicare and Medicaid Services. MIPS Quality Measures. https://qpp.cms.gov
- International Council for Harmonisation. ICH E6(R2) Good Clinical Practice. 2016.
